Configo Health is a healthcare data and analytics company that specializes exclusively in pediatrics. It helps children's hospitals and their teams make better decisions through the use of timely, trusted, and actionable insights. Configo Health provides HIPAA-compliant processes, secure data storage facilities, data cleansing, and sophisticated analytical processing. By analyzing and evaluating data, organizations can reduce serious safety events, reduce mortality rates, optimize length of stay, and reduce readmissions.
Configo Health's flagship product is the Opus benchmarking platform, which currently serves the needs of Quality & Safety, Diversity, Equity & Inclusion, and Surgery departments. In April 2020, the company launched the Covid-19 Recovery Accelerator, an online tool that allowed children's hospitals to scenario plan and optimize the managed ramp-up of elective procedure volume during the pandemic.
In November 2019, Configo Health announced investments from Texas Children's Hospital and Children's National Hospital, two of the top children's hospitals in the nation. The company was founded in 2019 and initially had offices in New York and Washington, DC In April 2022, Configo Health raised USD 2 million in funding led by the Pisgah Fund and relocated its headquarters to Asheville, NC, as part of a broader commitment to grow a health analytics hub in Western North Carolina. The company is forecasting 300% growth in 2022.
In August 2023, Configo Health appointed David Bertoch, a leading expert in pediatric healthcare data analytics, as Executive Vice President of Pediatric Analytics and Research Programs. Bertoch previously led data programs at the Children's Hospital Association for over two decades.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.